参考文献/References:
[1] 王 森,黄太宏,高 硕,等.系统性红斑狼疮患者乙型肝炎病毒感染的分析研究[J].现代检验医学杂志,2016,31(1):41-43.
Wang S,Huang TH,Gao S,et al.Prevalence of hepatitis B virus infection in systemic lupus erythematosus patients[J].J Mod Lab Med,2016,31(1):41-43.
[2] Trepo C,Chan HL,Lok A.Hepatitis B virus infection[J].Lancet,2014,384(9959):2053-2063.
[3] Wang L,Wang K,Zou ZQ.Crosstalk between innate and adaptive immunity inhepatitis B virus infectio[J].World J Hepatol,2015,7(30):2980-2991.
[4] Boraschi D,Lucchesi D,Hainzl S,et al.IL-37:a new anti-inflammatorycytokine of the IL-1 family[J].Eur Cytokine Netw,2011,22(3):127-147.
[5] 中华医学会肝病学分会,中华医学会感染病学分会.慢性乙型肝炎防治指南(2015年版)[J].中华实验和临床感染病杂志(电子版),2015,9(5):570-589.
Chinese Society of Hepatology,and Chinese Society of Infectious Diseases Chinese Medical Association.The guideline of prevention and treatment forchronic hepatitis B:2015 update[J].Chinese Journal of Experimental and Clinical Infectious Diseases(Electronic Version),2015,9(5):570-589.
[6] 任翠平,高闻达,沈际佳.IL-37免疫学作用研究进展[J].国际医学寄生虫病杂志,2014,41(1):41-43.
Ren CP,Gao WD,Shen JJ.Research progress on the immunological functions of IL-37[J].International Journal of Medical Parasitic Diseases,2014,41(1):41-43.
[7] Dinarello CA,Nold-Petry C,Nold M,et al.Suppression of innate inflammation and immunity by interleukin-37[J].Eur J Immunol,2016,46(5):1067-1081.
[8] 张 燕,熊 霞.IL-37及其与疾病相关性的研究进展[J].基础医学与临床,2015,35(4):549-553.
Zhang Y,Xiong X.Research progress on IL-37 and the correlation with diseases[J].Basic &Clinical Medicine,2015,35(4):549-553.
[9] 李腾达,陈 燕,龙曙萍,等.原发性胆汁性肝硬化患者外周血单个核细胞中IL-37表达增高及临床意义[J].现代检验医学杂志,2017,32(1):12-15.
Li TD,Chen Y,Long SP,et al.Increasing expression of IL-3 7 in peripheral blood mononuclear cell of patients with primary biliary cirrhosis andits clinical significance[J].J Mod Lab Med,2017,32(1):12-15.
[10] Li C,Ji H,Cai Y,et al.Serum interleukin-37 concentrations and HBeAg seroconversion in chronic HBV patients during telbivudine treatment[J].J Interferon Cytokine Res,2013,33(10):612-618.
[11] Shi B,Ren G,Hu Y,et al.HBsAg inhibits IFN-alpha production in plasmacytoid dendritic cells through TNF-alpha and IL-10 induction in monocytes[J].PLoS One,2012,7(9):e44900.
收稿日期:2017-08-09 修回日期:2017-08-30
相似文献/References:
[1]惠凌云,王 凌,张 琳,等.CHB患者疾病进程与抑郁症的程度及血清BDNF水平的相关性[J].现代检验医学杂志,2015,30(03):13.[doi:10.3969/j.issn.1671-7414.2015.03.004]
HUI Ling-yun,WANG Ling,ZHANG Lin,et al.Correlation of the Disease Process,Depression
Severity and Serum Levels of BDNF in Patient with CHB[J].Journal of Modern Laboratory Medicine,2015,30(06):13.[doi:10.3969/j.issn.1671-7414.2015.03.004]
[2]李步荣,张彤,李丽华,等.CHB患者HBV基因型及耐药突变基因联合检测临床研究[J].现代检验医学杂志,2015,30(05):40.[doi:10.3969/j.issn.1671-7414.2015.05.012]
LI Bu-rong,ZHANG Tong,LI Li-hua,et al.Clinical Study of Combined Detection about Hepatitis B Virus Genotypes
and Drug Resistant Mutation Genes in Patients with Chronic Hepatitis B[J].Journal of Modern Laboratory Medicine,2015,30(06):40.[doi:10.3969/j.issn.1671-7414.2015.05.012]
[3]徐晓嵘a,章晓鹰a,张珏a,等.干扰素治疗慢性乙型肝炎HBeAg血清学转换预测指标价值比较[J].现代检验医学杂志,2015,30(05):146.[doi:10.3969/j.issn.1671-7414.2015.05.046]
XU Xiao-ronga,ZHANG Xiao-yinga,ZHANG Juea,et al.Comparison of the Values for Predicting HBeAg Seroconversion
in the Treatment of Chronic Hepatitis B by PEG-IFN[J].Journal of Modern Laboratory Medicine,2015,30(06):146.[doi:10.3969/j.issn.1671-7414.2015.05.046]
[4]唐四海.慢性乙型肝炎患者血清胱抑素C水平与其肝损伤程度的关系[J].现代检验医学杂志,2016,31(04):146.[doi:10.3969/j.issn.1671-7414.2016.04.042]
TANG Si-hai.Relationship between the Level of Serum Cystatin C
and Degree of Liver Damage in Patients with Chronic Hepatitis B[J].Journal of Modern Laboratory Medicine,2016,31(06):146.[doi:10.3969/j.issn.1671-7414.2016.04.042]
[5]李腾达,陈 燕,龙曙萍,等.原发性胆汁性肝硬化患者外周血单个核细胞中IL-37表达增高及临床意义[J].现代检验医学杂志,2017,32(01):12.[doi:10.3969/j.issn.1671-7414.2017.01.004]
LI Teng-da,CHEN Yan,LONG Shu-ping,et al.Increasing Expression of IL-37 in Peripheral Blood Mononuclear Cell
of Patients with Primary Biliary Cirrhosis and Its Clinical Significance[J].Journal of Modern Laboratory Medicine,2017,32(06):12.[doi:10.3969/j.issn.1671-7414.2017.01.004]
[6]王福玲.血清miR-122,ALT及HBV-DNA定量检测对慢性乙型肝炎患者诊断的意义[J].现代检验医学杂志,2017,32(04):67.[doi:10.3969/j.issn.1671-7414.2017.04.019]
WANG Fu-ling.Diagnostic Value of Serum miR-122,ALT and HBV-DNA
in Patients with Chronic Hepatitis B[J].Journal of Modern Laboratory Medicine,2017,32(06):67.[doi:10.3969/j.issn.1671-7414.2017.04.019]
[7]马 莹,姜小建,赵 佳.血清免疫球蛋白检测在慢性乙型肝炎和乙肝肝硬化中的临床意义[J].现代检验医学杂志,2018,33(05):123.[doi:10.3969/j.issn.1671-7414.2018.05.034]
MA Ying,JIANG Xiao-jian,ZHAO Jia.Clinical Significance of Serum Immunoglobulin Detection in Chronic Hepatitis B and Hepatitis B Cirrhosis[J].Journal of Modern Laboratory Medicine,2018,33(06):123.[doi:10.3969/j.issn.1671-7414.2018.05.034]
[8]刘宗萍.慢性乙肝患者血清 Tim-3，HBsAg，TGF-β1水平表达与病情程度相关性研究[J].现代检验医学杂志,2019,34(06):77.[doi:10.3969 ／ j.issn.1671-7414.2019.06.019]
LIU Zong-ping.Study on the Correlation between the Expression of Serum Tim-3, HBsAg,
TGF-beta 1 and the Severity of Chronic Hepatitis B[J].Journal of Modern Laboratory Medicine,2019,34(06):77.[doi:10.3969 ／ j.issn.1671-7414.2019.06.019]
[9]郭 堑,农村立,韦秋芳.慢性乙型肝炎肝纤维化患者血清Copeptin 和PCT 表达水平及其临床价值研究[J].现代检验医学杂志,2023,38(02):112.[doi:10.3969/j.issn.1671-7414.2023.02.021
]
GUO Qian,NONG Cun-li,WEI Qiu-fang.Serum Copeptin and PCT Expression Levels and Their Diagnostic Value in Patients with Hepatitis B Liver fibrosis[J].Journal of Modern Laboratory Medicine,2023,38(06):112.[doi:10.3969/j.issn.1671-7414.2023.02.021
]
[10]吕承秀a,c,陈 梅b,等.慢性乙型肝炎患者接受核苷（酸）类似物治疗后发生低病毒血症的危险因素及机制研究[J].现代检验医学杂志,2023,38(05):133.[doi:10.3969/j.issn.1671-7414.2023.05.025]
L? Chengxiua,c,CHEN Meib,et al.Risk Factors and Mechanism of Low-level Viremia in Patients with Chronic Hepatitis B Receiving Nucleos(t)ide Analogues Treatment[J].Journal of Modern Laboratory Medicine,2023,38(06):133.[doi:10.3969/j.issn.1671-7414.2023.05.025]